Clorox (NYSE:CLX) Releases Quarterly Earnings Results, Beats Estimates By $0.16 EPS

Clorox (NYSE:CLX) posted its quarterly earnings data on Monday. The company reported $1.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.16, RTT News reports. Clorox had a net margin of 4.78% and a return on equity of 316.08%. During the same period in the previous year, the firm earned $2.16 earnings per share. Clorox updated its FY 2025 guidance to 6.950-7.350 EPS.

Clorox Stock Performance

NYSE:CLX opened at $159.80 on Tuesday. Clorox has a 52 week low of $127.60 and a 52 week high of $171.37. The company has a fifty day simple moving average of $162.76 and a two-hundred day simple moving average of $158.50. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The company has a market cap of $19.78 billion, a price-to-earnings ratio of 55.68, a price-to-earnings-growth ratio of 2.92 and a beta of 0.42.

Clorox Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be issued a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 3.05%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s dividend payout ratio is presently 170.04%.

Analyst Ratings Changes

A number of research firms recently weighed in on CLX. Royal Bank of Canada reissued a “sector perform” rating and issued a $150.00 target price on shares of Clorox in a research note on Thursday, January 30th. JPMorgan Chase & Co. raised their price objective on Clorox from $167.00 to $171.00 and gave the company a “neutral” rating in a report on Thursday, January 16th. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and raised their target price for the stock from $155.00 to $170.00 in a research note on Wednesday, November 6th. StockNews.com downgraded shares of Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Finally, DA Davidson lifted their price target on Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a research note on Monday, November 4th. Four analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $156.07.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.